Genkwanin exerts anti-inflammatory effects mainly through decreasing miR-101 production. by Yuan Gao (159945)

Methylation levels of the <i>Ucp1</i> promoter decreased following genistein (GEN) treatment. by Noriko Sato (201880)

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…<p>Two independent groups evaluated GCase activity in whole brain homogenate (A,C) and liver homogenate (B,D) using different methods—The CBE/4-MU method (A,B) and the MDW941 method (C,D). …”

Silencing of SphK1, but not SphK2, decreases HPAEC migration by S1P in wound healing ECIS assay. by Evgeny V. Berdyshev (307465)

Elevated Ang2 expression and decreased Ang1 expression during <i>O</i>. <i>tsutsugamushi</i> infection. by Brandon Trent (8520288)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Infection with <i>Shigella flexneri</i> M90T<i>ΔaroA</i> results in a decrease in TAMs number. by Katharina Galmbacher (252251)

Increased body weight and decreased expansion of pro-inflammatory CD4+ T-cells from blood in Tg-HD5 rats. by Osiris Marroquin Belaunzaran (224031)

Oral UOX decreased SUA (A), BUN (B) and Cr (C) (mean ± SD, n = 10). by Yu Yun (4710340)

Serum samples and 50% NAI values. Serum samples taken from CEIRS study. by Harrison Powell (9040128)

Subjects:

CHO cell line stably transfected to synthesize rhTSG-6 forms aggregates resulting in a decrease of protein production. by Dong-Ki Kim (847216)

Truncation or mutation of MinE’s membrane targeting sequence decreases the lower limit of the length scale of Min protein patterns. by Simon Kretschmer (1871506)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

“…^#P<0.05; ^## P<0.01; ^### P<0.001 between bars, two-way ANOVA followed by Bonferroni test. Scale bars: 50 µm. fPSA: functional PSA mimetic peptide; MAP-2: microtubule-associated protein 2; NCAM: neural cell adhesion molecule; SYN: synaptophysin.…”

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”

Blockade of kinin B₁R in the chronic disease phase decreased the clinical symptoms and neuroinflammation in the EAE model. by Rafael C. Dutra (205755)

FAST protein expression in A549 cells decreases cellular metabolic activity, promotes apoptosis and concomitant loss of membrane integrity. by Carmen M. Wong (3176730)

LiCl and MTR decrease polyQ toxicity measuring ASH neuronal death in the absence of growth. by Cindy Voisine (30589)

JBPOS0101 decreased Amyloid Beta (Aβ) aggregates in the cortex and hippocampal regions in 5xFAD mouse brains. by Jihoon Jeong (4852690)